Endocrine therapy resistance: what we know and future directions
Endocrine resistance is a major hurdle in the treatment of estrogen receptor (ER)-positive breast cancer. When abnormally regulated, molecular signals responsible for cellular proliferation, as well as ER itself, allow for cellular evasion of ER-dependent treatments. Therefore, pharmacological treat...
Saved in:
Main Authors: | David Musheyev (Author), Anya Alayev (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What we know about the femininity of the future
by: Ю. Г. Антипкін, et al.
Published: (2018) -
Rabies : What We Know and What We Need to Know
by: Sandhu TS
Published: (2004) -
International Trade and Investment and Food Systems: What We Know, What We Don't Know, and What We Don't Know We Don't Know
by: Ashley Schram, et al.
Published: (2021) -
Paediatric schistosomiasis: What we know and what we need to know.
by: Derick N M Osakunor, et al.
Published: (2018) -
The Private Library What We Do Know, What We Don't Know, What We Ought to Know About Our Books
by: Humphreys, Arthur Lee, 1865-1946